Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-13 · accession 0001437749-25-020375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-16 | 2025-06-13 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $0.78 | +5,000 | 53.5K | +10% | +$3,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | P | A | 5,000 | $0.78 | 53,519 | D | — | — | (F1) Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |